Sentences with phrase «cancer cells into»

The nodes release cancer cells into the lungs and liver, creating secondary cancers in those locations.

Converting cancer cells into programmed apoptosis is characteristic of most natural alternative methods of killing cancer cells.

In the book Cancer & Natural Medicine — A Textbook of Basic Science and Clinical Research, author John Boik identifies a dozen substances which have been shown in vitro to be able to revert cancer cells into normal cells (he calls it «differentiation»).

In other words, even natural cancer treatments that kill cancer cells or revert cancer cells into normal cells can have the cancer return.

Tests have exhibited how this natural ingredient can trick the cancer cells into killing themselves, which has resulted to tumors shrinking to almost half of its original size.

DMSO has also been shown, by itself, to revert cancer cells into normal cells.

In addition, the Royal Rife technology, which also reverts cancer cells into normal cells, has been replicated and improved upon.

The ICRF researcher who discovered how microbes block the ATP energy also developed about 25 different ways to kill these microbes while they are inside the cancer cells (the microbe is actually a bacteria — Helicobacter Pylori) thereby reverting the cancer cells into normal cells.

This is when the highly alkaline baking soda kills the microbes inside the cancer cells, thus reverting the cancer cells into normal cells.

As with other MSM protocols, this protocol uses MSM to get colloidal silver inside the cancer cells to kill the microbes and revert the cancer cells into normal cells.

However, microbes have been shown to die by colloidal silver, thus the focus of this treatment is to get colloidal silver inside the cancer cells in order to kill the microbes and revert the cancer cells into normal cells.

They break down cancer cells into smaller pieces (including antigens) and then hold out these antigens so T cells can see them.

The test involves aggregating human prostate cancer cells into microtissues in 96 - well plates and monitoring their growth over 90 days.

At the prestigious American Association for Cancer Research annual meeting this week, MedImmune will unveil for the first time how we are packing a one - two punch to cancer cells into one specially - engineered monoclonal antibody.

The experimental metastasis assay we detail here includes tail - vein injection of cancer cells into the mouse and determination of the resulting secondary organ colonization, primarily in the lung, 10 d post dosing.

Researchers are now exploring whether using a drug to block ATM could trick cancer cells into ignoring the damage signals so that radiation effectively destroys more cancer cells.

However, when Allison Cleary transplanted MMTV - Wnt1 cancer cells into other mice and removed their Wnt1, the tumors continued to develop.

In both cases, paclitaxel changed the tumor microenvironments in three ways, all more conducive to metastasis: The microenvironment had more of the immune cells that carry cancer cells into blood vessels, it developed blood vessels that were more permeable to cancer cells, and the tumor cells became more mobile, practically bounding into those molecular Lyfts.

It puts cancer cells into a permanent sleep so they no longer divide and grow in an uncontrolled way.

The importance of stromal POSTN was also demonstrated in another study in which orthotopic inoculation of gastric cancer cells into Rag2 − / −; Postn − / − mice reduced tumor size, decreased invasiveness, and decreased growth compared to Rag2 − / −; Postn + / + mice (Kikuchi et al., 2014).

For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.

Studying the process, Welm and her colleagues inserted breast cancer cells into mouse bones.

Researchers have tricked glucose - eating cancer cells into consuming a sugar that essentially poisons them — it leaves a «suicide» switch within the cells open to attack.

The technique typically homes in on circulating - tumor DNA (ctDNA), genetic material that routinely finds its way from cancer cells into the bloodstream.

«Vitamin deficiency «puts cancer cells into hibernation».»

Next, the researchers transplanted metastasizing human colon cancer cells into a different set of mice.

They placed the human cancer cells into the incubator and lowered the oxygen to a level comparable to that in a tumour.

Instead, following exposure to chemotherapy, GSTO1 binds to a protein called the ryanodine receptor 1, or RYR1, that triggers the release of calcium, which causes a chain reaction that transforms ordinary breast cancer cells into cancer stem cells.

Finally, using live mice, the scientists injected 1,000 triple - negative breast cancer cells into their mammary fat pads, where the mouse version of breast cancer forms.

When the scientists inserted human colorectal cancer cells into zebrafish embryos and allowed them to grow for 4 days, the resulting tumors showed three hallmarks of human solid tumors: rapid cell division, formation of blood vessels to supply nutrients, and the ability to spread to other locations in the body.

To create mouse avatars, researchers implant some of a patient's cancer cells into rodents lacking a normal immune system and measure whether various drugs destroy the tumors that sprout in the animals.

All are examples of translational researchers converting molecular knowledge about specific cancer cells into effective, targeted therapies.

She demonstrated that early experience leads to lasting changes in the molecular structure of the brain and discovered a gene involved in the spread of brain cancer cells into healthy brain tissue.

The front - page headline of the New York World - Telegram on Jan. 20, 1964 shocked readers: «Charge Hospital Shot Live Cancer Cells Into Patients.»

We suspect that a God who requires compensation just might encrypt a cancer cell into our tissue in order to teach us an ethical lesson or send a surging tsunami to pummel a coastline for the sake of some cosmic moral equation.

Not exact matches

Instead of being injected into the bloodstream and exposed to the rest of the body's tissue — with all the unpleasant side effects, as is the case with chemotherapy — these agents only target cancer cells.

Basically, CAR - T therapy involves taking a patient's own immune «killer» T - cells, inserting new genetic code into those cells which turn them into cancer - hunters that can home in on malignant B - cells (another kind of immune cell), and then pumping these specialized leukemia - busting cells back into the patient.

Immune cells modified by CRISPR - Cas9 were inserted into a lung cancer patient at the West China Hospital in Chengdu in the hopes that they'll be able to fight tumors, and 10 people total will receive injections of CRISPR re-engineered cells in order to assess the method's safety.

Researchers from the Sichuan University in Chengdu inserted the re-engineered cells into a lung cancer patient participating in a clinical trial at the West China Hospital on October 28th, according to Nature.

The treatment is a type of so - called CAR T - cell therapy — taking a patient's own immune cells, called T cells, genetically manipulating them to attack specific proteins on cancer, and infusing them back into the patient.

Speaking of Novartis — the company's experimental CTL019, which is expected to be the first approved drug in a revolutionary new cancer treatment space that turns the body's own immune cells into cancer - killers, is already facing some apprehension from doctors and patient groups who are worried about its eventual pricing.

In clinical trials the treatment — which involves extracting individual patients» immune T - cells, modifying them to seek out tell - tale biological markers associated with blood cancers like aggressive lymphoma, and then pumping those modified killer cells back into the body — has shown major promise, in some cases eliminating all signs of the cancer in patients six months after treatment.

Biotech giant Gilead Sciences is beefing up its cancer drug portfolio with a $ 11.9 billion deal to buy Kite Pharma, a company focused on a groundbreaking new class of treatments that turns the body's own immune cells into targeted blood cancer killers.

Those two companies, along with their larger competitor Novartis (nvs), are developing experimental chimeric antigen receptor T - cell (CAR - T) technology platforms, which are highly personalized treatments that involve extracting patients» immune cells, re-engineering them to target their specific cancers, and then pumping these sniper - cells back into the body.

The novel treatment space involves transforming a patient's own immune T - cells into cancer - busting weapons.

Bellicum is among the flurry of biotechs investing heavily into cell therapies such as experimental chimeric antigen receptor T - cell (CAR - T) treatments for cancer (this is the next - gen treatment that involves reprogramming immune cells to become cancer killers and has shown promise in blood cancers, which Bellicum specializes in).

This new kind of approach to fighting blood cancers is truly personalized; immune T - cells are extracted from patients, genetically tinkered to home in on an destroy cancerous cells, multiplied in a lab, and then jolted back into the patient's body within about two weeks.

The biotech has been jockeying against main rivals Novartis and Juno to secure a first - to - market advantage with the groundbreaking new medical tech, which turns patients» immune cells into souped - up, re-engineered cancer killers that are then reintroduced into the body.

As a cancer researcher, do you think the mechanisms of tumor growth are somehow changing to come into line with your perceptions, or is it possible that the process of our learning more about DNA mutations and cell architecture and nutrient exchange and epigenetic effects make it possible for us to inch ever closer to understanding that which is already going on under our noses?

This makes me happy: Microglia cells migrate into tumors and supply cancer cells with a substance needed for the repair of DNA damage.